Redeye was hoping for somewhat higher sales but is encouraged by solid gross margins of 36% in the q...
The 18th of October, and on the 19th of October, Eevia Health (“Eevia” or “the company”) the company...
Redeye provides a first comment on the back of XMReality’s Q3 report.
New net profit guidance DKK 140m-170m (160m-190m) Our expected rate path implies ‘23e income of DKK...
Q3 report due on Friday, 11 November We lower our ’23e EBIT by 2% Improved infrastructure will boo...
Suominen reports Q3 results on Oct 26. We make only minor estimate revisions ahead of the report as ...
Idefirix accounts a relatively solid Q3 despite holiday interruptions.
Safeture's ARR and net revenue were in line with Redeye's estimates, and the company continues to sh...
Redeye comments on Invisio ahead of its Q3-results (due 27 October) where we expect a sequential imp...
Redeye leaves a short comment following Lipum’s announcement yesterday regarding the outcome of the ...
Redeye initiates coverage of Sozap, a Swedish digital entertainment company developing free-to-play ...
Efter flera år av tillväxt och lönsamhet väl över sektorkollegorna, har Angler Gaming stött på patru...
On the 19th of October 2022, Brain+ A/S (“Brain+” or the "Company”) announced that the Company has b...
Redeye is positive about Smart Eye's announcement of a new platform deal from an existing OEM custom...
Redeye comments on recent partnerships, including a Chinese intelligent vision and software solution...
Redeye is positive to the news of a direct share issue done yesterday that will bring SEK 25m before...
We expect Q3 rev. of DKK 236m & a ~19% EBIT margin Downgrade of FY’22 guidance not unlikely Unlike...
Raute reports Q3 results on Oct 21. We expect gradual improvement amid inflation and shift to Wester...
Redeye comments on recent partnerships, including with a Chinese intelligent vision and software sol...
Yesterday evening Xbrane carried out a directed share issue of SEK 170m to strengthen the balance sh...
